ライフサイエンスコーパス: patient presenting with

1 ped two standardised patient cases: first, a patient presenting with 2-3 weeks of pulmonary tuberculo

2 Ten healthy adult patients presenting with 21 Miller Class I gingival rece

3 -side-to-end strictureplasty is performed in patients presenting with 3 severely fibrotic and deforme

4 onsidered in the differential diagnosis of a patient presenting with a gradually progressive orbital

5 Case Report: A middle-aged female patient presenting with a history of multiple chronic ne

6 ncy intervention to individuals exposed to a patient presenting with a late reactivation of EVD.

7 Here, we report a case of a patient presenting with a lung mass 3 years after lung t

8 Furthermore, in a patient presenting with a severe form of primary microce

9 cilli (GNB) bloodstream infections (BSIs) in patients presenting with a beta-lactam (BL) allergy is o

10 In patients presenting with a clinically isolated syndrome,

11 ly, these findings suggest that mesothelioma patients presenting with a family history of cancer shou

12 cohort, rectosigmoidal VM occurred in 5% of patients presenting with a high incidence of rectal blee

13 raniectomy, and improve clinical outcomes in patients presenting with a large hemispheric infarction.

14 ted on the use of the following protocol for patients presenting with a Los Angeles Motor Scale score

15 sequencing and autozygome-based screening of patients presenting with a peculiar, recessive form of c

16 Patients presenting with a penetrating chest wound and a

17 Young patients presenting with a solitary meningioma or schwan

18 Patients presenting with a worse initial visual acuity (

19 The typical clinical scenario is a young patient presenting with abdominal pain, chronic diarrhoe

20 us complication must always be remembered in patients presenting with abdominal pain after stent inse

21 ary presentation, treatment, and outcomes of patients presenting with acute (A), perforated (P), and

22 emic immune responses in peritoneal dialysis patients presenting with acute bacterial peritonitis and

23 he ESC 0/1-h algorithm for the management of patients presenting with acute chest discomfort to the E

24 a prospective international study enrolling patients presenting with acute chest discomfort to the e

25 ould be considered and diagnosed promptly in patients presenting with acute chest or back pain and hi

26 presents an attractive alternative to triage patients presenting with acute chest pain.

27 Conjunctival swabs were collected from patients presenting with acute conjunctivitis.

28 after percutaneous coronary intervention in patients presenting with acute coronary syndrome is inde

29 cute Coronary Syndrome (APTITUDE-ACS) study, patients presenting with acute coronary syndrome or for

30 after percutaneous coronary intervention in patients presenting with acute coronary syndrome.

31 iously thought and is present in up to 4% of patients presenting with acute coronary syndrome.

32 est CT to abdominal CT to detect COVID-19 in patients presenting with acute gastrointestinal symptoms

33 was developed to predict 30-day mortality in patients presenting with acute heart failure (AHF) to em

34 Eligible participants were patients presenting with acute ischaemic stroke from ant

35 to >35% and >/=50% after 90-day follow-up in patients presenting with acute MI and severe LV dysfunct

36 re known to exist in the management of older patients presenting with acute myocardial infarction (AM

37 vessel percutaneous coronary intervention in patients presenting with acute myocardial infarction, mu

38 tudy population and for a subset of Medicare patients presenting with acute myocardial infarction.

39 of perceived stress in young and middle-aged patients presenting with acute myocardial infarction.

40 antly higher 30-day in-hospital mortality in patients presenting with acute myocardial infarction.

41 six Dutch centers included consecutive adult patients presenting with acute non-traumatic gastrointes

42 o address these early and late aspects, 2291 patients presenting with acute or stable coronary diseas

43 48 hours after recruitment from a cohort of patients presenting with acute pancreatitis.

44 h at a national level clinical outcomes from patients presenting with acute para-esophageal hernia (P

45 Patients presenting with acute respiratory infection wer

46 m a prospective cohort of 996 critically ill patients presenting with acute trauma and an injury seve

47 otential diagnosis should be kept in mind in patients presenting with acute upper abdomen pain and di

48 We describe two unrelated patients presenting with acute, reversible (and recurren

49 This study suggests that management of patients presenting with adhesive-SBO by a primary medic

50 mpare medical versus surgical treatments for patients presenting with advanced open angle glaucoma in

51 te diagnosis results in approximately 30% of patients presenting with advanced, irreversible organ in

52 All consecutive patients presenting with AF or atrial flutter on DOAC we

53 ticenter, prospective cohort study enrolling patients presenting with AHF requiring intravenous diure

54 manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating an

55 y of appendicitis must be entertained in any patient presenting with an acute abdomen.

56 the case of a 66-year-old anal cancer female patient presenting with an asymptomatic sub-hepatic mass

57 For patients presenting with an acute ST-segment-elevation m

58 ional diagnoses that should be considered in patients presenting with an acute TMA, especially in pat

59 Over 5 years in patients presenting with an FCDE, early sc IFN beta-1a t

60 used a Markov model to simulate a cohort of patients presenting with an initial CDI diagnosis.

61 Patients presenting with an isolated decline in FEV1 (FE

62 This study aimed to analyze how quickly patients presenting with anaphylaxis were treated in eme

63 characteristics were compared with those of patients presenting with anti-FH Ab-associated aHUS.

64 d response was defined as a composite of all patients presenting with any of the following outcomes:

65 he need for focus on underlying morbidity in patients presenting with apparent viral or idiopathic pe

66 In the United States, the majority of patients presenting with appendicitis receive CT imaging

67 (c.8488-1G>A and c.8524C>T) discovered in FA patients presenting with atypical FA-like phenotypes, we

68 Mutations of MAGEL2 have been reported in patients presenting with autism, and loss of MAGEL2 is a

69 considered in the differential diagnosis for patients presenting with bilateral uveitis without evide

70 One hundred P2Y12 inhibitor-naive patients presenting with biomarker-negative ACS and unde

71 e differential diagnosis of fumarate-treated patients presenting with brain lesions or seizures even

72 A total of 190 patients presenting with breast lesions were included in

73 be infectious to humans in 52 of 386 (13.4%) patients presenting with CA sepsis of unknown cause.

74 uting factor in myocardial infarction and in patients presenting with cardiomyopathy.

75 juana use is encouraged, especially in young patients presenting with cardiovascular disease.

76 Retrospective case series of all patients presenting with cavitary retinoblastoma between

77 Patients presenting with cavitary retinoblastoma who wer

78 presentative sample of adult Mexican Mestizo patients presenting with CD.

79 Differences in retention between patients presenting with CD4 counts just above versus ju

80 But up to 28 % of patients presenting with central retinal vein occlusion

81 itigating risk and treatment of HIV-positive patients presenting with CHD.

82 from a local database of patients to triage patients presenting with chest discomfort after PCI.

83 e used to measure troponin concentrations in patients presenting with chest-pain symptoms and being i

84 aluation and tests used in the assessment of patients presenting with chronic diarrhea are reviewed,

85 CKD-related mutation in approximately 20% of patients presenting with CKD before 25 years of age.

86 ization were greater for PVI than for LEB in patients presenting with claudication (12.3+/-2.7% and 1

87 This classification restricts patients presenting with clinical criteria characteristi

88 In patients presenting with clinical deterioration at follo

89 This is one of the largest studies examining patients presenting with clinical T1D in the presence of

90 ntinel lymph node biopsy (SLNB) after NAC in patients presenting with clinically negative nodes has a

91 We used whole exome sequencing in a VEOIBD patient presenting with colitis characterized by colonic

92 helpful in the evaluation and management of patients presenting with colonic perforation, especially

93 ied loss-of-function mutations in NSUN3 in a patient presenting with combined mitochondrial respirato

94 particular C-P4H-I, should be considered in patients presenting with congenital connective tissue/my

95 stic assessment, and therapeutic approach to patients presenting with CP and RCM.

96 single-centre retrospective-cohort study all patients presenting with CT-diagnosed uncomplicated left

97 al resection of the primary in breast cancer patients presenting with de novo stage IV disease.

98 Patients presenting with de novo stage IV metastatic bre

99 line the clinical evaluation indicated for a patient presenting with demyelinating polyneuropathy and

100 (DEB) and everolimus-eluting stents (EES) in patients presenting with DES-ISR.

101 d in conjunction with fundoplication even in patients presenting with device erosion.

102 Zambia and compared these with isolates from patients presenting with diarrhoea in the same region.

103 ate antiplatelet strategy for the individual patient presenting with different clinical manifestation

104 diagnosis should be considered primarily in patients presenting with distal weakness (foot drop) in

105 Among patients presenting with diverse neurological problems,

106 sk factors for CSF discordance and escape in patients presenting with diverse neurological problems.

107 the prevalence of five species of NHPGHs in patients presenting with dyspepsia.

108 ificial intelligence-enabled ECG to identify patients presenting with dyspnea who have left ventricul

109 considered in the differential diagnosis of patients presenting with dyspnea, congestion, and a norm

110 nd 83.6% and 88.3% (p = 0.335) at 1 year for patients presenting with early and late valve dysfunctio

111 national guidelines for the resuscitation of patients presenting with early septic shock.

112 are the most commonly assessed mutations in patients presenting with early-onset breast cancer, trip

113 The mean age of the 2081 patients presenting with early-onset myocardial infarcti

114 viding the possibility of definitive cure in patients presenting with early-stage disease.

115 Patients presenting with either intermittent claudicatio

116 Our results suggest that in patients presenting with either irregular ring shapes or

117 ospectively analysed a cohort of consecutive patients presenting with embolic stroke at an academic h

118 Here, we describe 2 patients presenting with end-stage lung disease and sign

119 er, in four EoE families, we have identified patients presenting with EoE-typical and corticosteroid-

120 Total sample included 246 patients presenting with ES (221 men; age: 65+/-9 years)

121 ormed to rule out acute coronary syndrome in patients presenting with exertional chest pain.

122 A substantial proportion of patients presenting with extrapulmonary TB have urogenit

123 ynthetase (mt-AlaRS) were first described in patients presenting with fatal infantile cardiomyopathy

124 a reliable means for controlling seizures in patients presenting with focal seizures.

125 Approximately 51% of patients presenting with frequent premature ventricular

126 A chart review of all patients presenting with full-thickness MH from exposure

127 From 1988 to 2014, all patients presenting with GA 16 to 60 years of age were e

128 arriage on days 7 and 14, most apparently in patients presenting with gametocytaemia on day 0 (Odds R

129 abdominal CT to detect possible COVID-19 in patients presenting with gastrointestinal symptoms.

130 a neurosurgical intervention were similar in patients presenting with GCS scores of 3 to 8 and GCS sc

131 eversal of dabigatran activity in nearly all patients presenting with GI bleeding, facilitating emerg

132 In this study, we studied 17 patients presenting with GP who were positive for anti-F

133 hageal varices were the commonest finding in patients presenting with haematemesis, increasing by 14

134 Retrospective analysis of patients presenting with haemoptysis yielded 24 (n = 24)

135 Hospitalized patients presenting with heart disease but not heart fai

136 ppears better than generally considered, but patients presenting with heart failure still have poor l

137 The virus was isolated from patients presenting with hemorrhagic manifestations and

138 Concurrent antibody screening of patients presenting with hepatitis symptoms documented p

139 eatment option that should be discussed with patients presenting with high-risk, non- metastatic, cas

140 concurrent illness might predispose certain patients presenting with hyperkalemia to a lower or high

141 be of interest to assist early diagnosis of patients presenting with hypomorphic DNA repair defects

142 ional radiology embolisations in a series of patients presenting with iatrogenic vascular injuries of

143 agnose, or treat underlying drug abuse among patients presenting with IDU-related infections.

144 Clinical characteristics of 8 patients presenting with in-the-bag intraocular lens dis

145 AF was present in 31% of patients presenting with index ventricular tachyarrhythm

146 58) were reported as symptoms, and longer in patients presenting with indigestion (0.71, 0.56-0.89; p

147 high suspicion for the development of AEF in patients presenting with infective, neurological, gastro

148 by RT-PCR were collected from the first ten patients presenting with influenza-like illness each wee

149 ry syndrome coronavirus 2 (SARS-CoV-2) among patients presenting with influenzalike illness who under

150 Patients presenting with initial shock-refractory VF/VT

151 We studied a patient presenting with insidious impairment of basic vi

152 (ECL) is essential for guiding treatment in patients presenting with intracerebral hemorrhage (ICH).

153 In patients presenting with IU-CRLM, combination systemic a

154 ression profiles of PBMCs from 43 drug-naive patients presenting with joint symptoms were evaluated a

155 quire physicians to comprehensively evaluate patients presenting with kidney stones.

156 A higher proportion of patients presenting with late presentation STEMI was obs

157 Patients presenting with left bundle branch block ventri

158 It carries mutations in patients presenting with limb-girdle muscular dystrophy

159 ents (AER 2.93 per 100 patient-years); 29 in patients presenting with lobar ICH (AER 3.12 per 100 pat

160 ate (AER) 1.88 per 100 patient-years); 35 in patients presenting with lobar ICH (n=447, AER 3.77 per

161 Patients presenting with low ML and low DD levels have l

162 Patients presenting with MC to the retina clinic over a

163 onsidered in the differential diagnosis of a patient presenting with meningeal symptoms, paraesthesia

164 vival of less than 10%, and more than 50% of patients presenting with metastatic disease.

165 al Infarction: Events and Recovery) enrolled patients presenting with MI at 31 US hospitals between 2

166 Corneal scrapes were collected from 267 patients presenting with microbial keratitis at a referr

167 genic YARS2 variants should be considered in patients presenting with mitochondrial myopathy, charact

168 oot planing (SRP) with and without EMD in 51 patients presenting with moderate to severe periodontiti

169 lasticity is not associated with age, but AD patients presenting with more altered LTP-like cortical

170 iles and was not explained by differences in patients presenting with multiple complications on the i

171 of all flow-limiting coronary lesions in 898 patients presenting with myocardial infarction (MI).

172 tumor is critical for surgical treatment of patients presenting with neuroendocrine tumor (NET) with

173 nvolved, so as to customize the treatment of patients presenting with neurological complications.

174 -1007 with (68)Ga-PSMA-11 PET/CT in the same patients presenting with newly diagnosed intermediate- o

175 In patients presenting with nfvPPA, presence of early sever

176 In patients presenting with node-positive disease, clinical

177 7, AER 3.77 per 100 patient-years); and 9 in patients presenting with non-lobar ICH (n=580, AER 0.69

178 le of complete coronary revascularization in patients presenting with non-ST-segment elevation myocar

179 AIS patients with elevated cTn compared with patients presenting with non-ST-segment-elevation acute

180 y increase the risk of administrating tPA to patients presenting with noncerebrovascular conditions t

181 e results of trial of hydroxychloroquine for patients presenting with nonsevere COVID-19.

182 In patients presenting with nonshockable cardiac rhythm aft

183 Bilateral findings were found in 7 of 10 patients presenting with ocular lesions, the most common

184 Patients presenting with older parasites, and with async

185 Eighteen (55%) of the 33 patients presenting with OMG converted to GMG at a media

186 pared with the observed standard of care for patients presenting with opioid use disorder to Californ

187 unadjusted rate of coronary angiography for patients presenting with out-of-hospital cardiac arrest

188 he utilization of coronary angiography among patients presenting with out-of-hospital cardiac arrest

189 sted likelihood of in-hospital mortality for patients presenting with out-of-hospital cardiac arrest

190 CASE PRESENTATION: A 30 year - old male patient presenting with pain to the upper abdomen due to

191 Of patients presenting with pain or peripheral nervous syst

192 aining clinical suspicion for botulism among patients presenting with paralytic illness to facilitate

193 Patients presenting with parkinsonian syndromes share ma

194 ear survival rate was significantly worse in patients presenting with patterns 3 and 4 RV remodeling

195 A total of 50 consecutive patients presenting with perianal fistulous disease fulf

196 Patients presenting with pericarditis recurrence while r

197 In smoking patients presenting with periodontitis, the periodontal

198 blinded review of skin biopsy specimens from patients presenting with plaques.

199 ogenase) in parapneumonic effusions.Methods: Patients presenting with pleural effusions were prospect

200 o analyze the outcome of hepatoblastoma (HB) patients presenting with post treatment extent of diseas

201 In additional patients presenting with PPGL and polycythemia, no furth

202 de a framework for the clinician assessing a patient presenting with predominantly LMN features.

203 we evaluate the management of a one-time new patient presenting with presumptive TB, which may not re

204 est CT to abdominal CT to detect COVID-19 in patients presenting with primarily acute gastrointestina

205 esent an unusual case of a kidney transplant patient presenting with progressive neurological deterio

206 We report a patient presenting with prolonged mild headaches and acu

207 s were similar in terms of the proportion of patients presenting with prolonged air leakage (7.8% in

208 Patients presenting with proven/probable LRTI had a medi

209 aining a careful occupational history in the patient presenting with pulmonary infiltrates and/or fib

210 INTERPRETATION: Patients presenting with pure autonomic failure are at h

211 d sensory neuropathies, including four young patients presenting with pure motor axonal neuropathy.

212 Patients presenting with rapid onset of cardiomyopathy,

213 Carotid webs should be suspected in a young patient presenting with recurrent unihemispheric strokes

214 n-PV triggers were found and targeted in all patients presenting with recurrent arrhythmia after >/=2

215 A human cardiac sample was obtained from a patient presenting with reduced left ventricular (LV) fu

216 Patients presenting with RVO to Creteil University Eye C

217 Among patients presenting with SAB and no signs of pocket infe

218 ify clinical predictors of CIED infection in patients presenting with SAB and no signs of pocket infe

219 istress syndrome, with possible exception of patients presenting with septic shock.

220 We report a case of a HLA-B27 negative patient presenting with severe, bilateral, idiopathic ac

221 ted to improve early outcomes, especially in patients presenting with severe disease and requiring in

222 s associated with a decreased probability of patients presenting with severe PAD and resolution of me

223 Consecutive patients presenting with severe sepsis or septic shock f

224 nism of severity and potential therapies for patients presenting with severe symptoms are scattered a

225 thin the aortic wall, should be suspected in patients presenting with severe thoracic pain and hypert

226 Twenty-nine consecutive patients presenting with severe uveitis that required an

227 patients met two or more SIRS criteria, and patients presenting with SIRS had higher in-hospital mor

228 6-20 years, among whom approximately 1 in 13 patients presenting with sore throat has mononucleosis).

229 In adolescent and adult patients presenting with sore throat, the presence of po

230 Patients presenting with spontaneous or drug-induced Bru

231 Patients presenting with spontaneous or drug-induced Bru

232 Patients presenting with spontaneous or drug-induced Bru

233 The diagnosis should be considered in patients presenting with sporadic episodes of haematuria

234 o compare the immunization status of grafted patients presenting with SSD following ATG induction tre

235 Two hundred thirty-one patients presenting with ST underwent OCT imaging; 14 (6

236 Consecutive patients presenting with ST were prospectively enrolled

237 In patients presenting with ST-segment elevation myocardial

238 lete ST-segment resolution 1 h after pPCI in patients presenting with ST-segment-elevation myocardial

239 imary percutaneous coronary intervention for patients presenting with ST-segment-elevation myocardial

240 Approximately half of the patients presenting with ST-segment-elevation myocardial

241 In patients presenting with ST-segment-elevation myocardial

242 In a follow-up study, 181 patients presenting with ST-segment-elevation myocardial

243 Patients presenting with ST-segment-elevation myocardial

244 For patients presenting with ST-segment-elevation myocardial

245 platelet P2Y(12) inhibitor is recommended in patients presenting with ST-segment-elevation myocardial

246 cutaneous coronary intervention among 95 925 patients presenting with ST-segment-elevation myocardial

247 n March 17, 2016, and December 21, 2017, 440 patients, presenting with ST-segment elevation myocardia

248 In diabetic patients presenting with stable chest pain, a CTA strate

249 In patients presenting with stable chest pain, low-attenuat

250 ntable electronic device (CIED) infection in patients presenting with Staphylococcus aureus bacteremi

251 In patients presenting with STEMI and concurrent COVID-19 i

252 A prior history of CABG in patients presenting with STEMI and undergoing PPCI does

253 tinguish ischemic from hemorrhagic stroke in patients presenting with stroke-like symptoms is essenti

254 Patients presenting with stromal keratitis were addition

255 MATERIAL/Sixty patients presenting with suprahyoid neck masses underwen

256 ntation in 2 cohorts: a diagnostic cohort of patients presenting with suspected AMI and a prognostic

257 ra and have diagnostic relevance for younger patients presenting with suspected cerebral amyloid angi

258 Not all patients presenting with suspected diverticulitis were e

259 In patients presenting with suspected inflammatory orbital

260 center diagnostic study enrolling unselected patients presenting with suspected non-ST-segment elevat

261 may be a more thorough diagnostic work-up in patients presenting with SVT.

262 MATERIAL/We included consecutive patients presenting with symptomatic and sonographically

263 Dex+AA in the treatment of AL amyloidosis in patients presenting with symptomatic heart failure is as

264 GKS decreased the risk of hemorrhage in CCM patients presenting with symptomatic hemorrhage.

265 Val) revealed by whole-exome sequencing in a patient presenting with symptoms of long-QT syndrome as

266 se an algorithm for laboratory evaluation of patients presenting with symptoms and signs of hemolytic

267 nd manage comorbid anxiety and depression in patients presenting with symptoms due to OA, with those

268 rded microRNA profiles in the PD effluent of patients presenting with symptoms of acute peritonitis a

269 Clinically, patients presenting with symptoms of gastritis, routinel

270 nfectious agents in specimens collected from patients presenting with symptoms of respiratory viral i

271 immunosuppression or as diagnostic tests in patients presenting with symptoms such as fever during n

272 sitive and 4 high-sensitivity cTn assays) in patients presenting with symptoms suggestive of acute my

273 , multicenter, randomized trial, we enrolled patients presenting with symptoms suggestive of an ACS a

274 A total of 3155 patients presenting with symptoms suggestive of cardiac

275 The final diagnosis was adjudicated in patients presenting with symptoms suggestive of myocardi

276 Unselected patients presenting with syncope to the ED were prospect

277 Among 1,397 patients presenting with syncope to the ED, PE was detec

278 enefit or harm of systematic PE screening in patients presenting with syncope to the ED.

279 The prevalence of pulmonary embolism (PE) in patients presenting with syncope to the emergency depart

280 to diagnose and manage the broad spectrum of patients presenting with syncope.

281 At last follow-up, none of the 5 patients presenting with T3bN0M0, nor the patient with T

282 an estimate of the prevalence of smoking in patients presenting with their first episode of psychosi

283 The prevalence of smoking in patients presenting with their first episode of psychosi

284 3-center, prospective study, we enrolled 114 patients presenting with their first MI.

285 Patients presenting with their first STEMI and early QW

286 Patients presenting with these findings should be follow

287 Patients presenting with this syndrome have had recent e

288 2, p<0.0001), with greatest benefit noted in patients presenting with TIA or minor stroke (at 0-2 wee

289 ue-stage FMF was almost identical to that of patients presenting with tumors (10-year OS, 25% vs 27%)

290 Ten healthy adult patients presenting with twenty-one Millers Class I rece

291 ng for CSF1R mutations is essential in adult patients presenting with undefined CNS vasculitis or a l

292 Serum chymase levels were measured in patients presenting with undifferentiated fever to hospi

293 and SLC13A3 mutations should be screened in patients presenting with unexplained reversible leukoenc

294 rst diagnosis of RSV infection was lowest in patients presenting with URTI (31 of 197 [16%]).

295 acy in a paediatric cohort of 30 undiagnosed patients presenting with variable neurometabolic phenoty

296 1,993 consecutive patients presenting with ventricular tachyarrhythmias (i

297 e, this study evaluates this impact of AF in patients presenting with ventricular tachyarrhythmias.

298 ia care (MAC) and general anesthesia (GA) in patients presenting with vertebrobasilar occlusion strok

299 beds, particularly in asymptomatic males, in patients presenting with visceral artery FMD.

300 ischarge summaries, along with 20 additional patients presenting with VOC, but without ACS (controls)